Key facts
- This page summarizes Robert L. Dixon Jr.'s Form 4 filing for Elevance Health, Inc. (ELV).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 12 Jun 2026, 16:12.
Robert L. Dixon Jr. - 11 Jun 2026 Form 4 Insider Report for Elevance Health, Inc. (ELV)
- Reporting relationship
- Director
- Issuer ticker
- ELV
- Reported as of
- 11 Jun 2026
- Net transaction value
- -$60,667
- SEC form
- 4
- Accepted by SEC
- 12 Jun 2026, 16:12:50 UTC
- Prior SEC filing
- 15 May 2026
- Next SEC filing
- 22 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kathleen S. Kiefer, Attorney in fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert L. Dixon Jr. filed Form 4 for Elevance Health, Inc. (ELV) on 12 Jun 2026.
Change
- Previous filing in this sequence was filed on 15 May 2026.
- Current net transaction value: -$60,667.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001524849
Primary reporting owner
Dixon Robert L JR
- Relationship
- Director
- Address
- 220 VIRGINIA AVENUE, INDIANAPOLIS
- Signature
- /s/ Kathleen S. Kiefer, Attorney in fact
- Signature date
- 12 Jun 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ELV
transaction
Common Stock
Sale
- Transaction value
- $60,667
- Shares
- -151
- Change %
- -1.4%
- Price
- $401.77
- Shares after
- 10,734
- Date
- 11 Jun 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.